LQDA logo

LQDA
Liquidia Corp

4,250
Mkt Cap
$3.24B
Volume
900,821.00
52W High
$46.67
52W Low
$11.26
PE Ratio
-44.21
LQDA Fundamentals
Price
$36.77
Prev Close
$36.61
Open
$36.60
50D MA
$37.75
Beta
0.85
Avg. Volume
1.96M
EPS (Annual)
-$0.8009
P/B
71.66
Rev/Employee
$732,962.96
$2,975.43
Loading...
Loading...
News
all
press releases
Liquidia (NASDAQ:LQDA) Insider Scott Moomaw Sells 18,314 Shares
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) insider Scott Moomaw sold 18,314 shares of the business's stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an...
MarketBeat·19h ago
News Placeholder
More News
News Placeholder
Scott Moomaw Sells 18,314 Shares of Liquidia (NASDAQ:LQDA) Stock
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) insider Scott Moomaw sold 18,314 shares of the stock in a transaction that occurred on Monday, March 23rd. The stock was sold at an average price...
MarketBeat·1d ago
News Placeholder
Liquidia Stock Up 135% as Insider Sells $1.3 Million in Shares
Key PointsThe chief medical officer of Liquidia sold 35,365 common shares on March 13, 2026, for a transaction value of $1.28 million at around $36.30 per share...
Nasdaq News: Markets·2d ago
News Placeholder
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma
Bristol Myers expands Opdivo's reach with new U.S. and EU approvals in Hodgkin lymphoma, strengthening its immunotherapy leadership and growth outlook.
Zacks·4d ago
News Placeholder
GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer
GSK secures Japan orphan drug status for risvutatug rezetecan in SCLC, adding to multiple global designations backed by promising early data.
Zacks·4d ago
News Placeholder
Liquidia (NASDAQ:LQDA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Wells Fargo & Company upped their price target on Liquidia from $44.00 to $51.00 and gave the company an "overweight" rating in a report on Monday...
MarketBeat·4d ago
News Placeholder
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
NVS bets $2B upfront on SNV4818 to expand precision oncology in breast cancer, targeting a large mutation-driven market and boosting long-term pipeline growth.
Zacks·6d ago
News Placeholder
Best Low-Beta Stocks to Own Right Away: AGRO, PRA, E & LQDA
Low-beta picks gain focus as Iran war fears stir volatility. AGRO, PRA, E and LQDA reflect resilience with momentum, liquidity and fundamentals.
Zacks·8d ago
News Placeholder
Liquidia Corporation $LQDA Shares Sold by Mirabella Financial Services LLP
Mirabella Financial Services LLP decreased its position in Liquidia Corporation (NASDAQ:LQDA - Free Report) by 45.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 247,405 shares of the company's stock a...
MarketBeat·8d ago
News Placeholder
Can Liquidia Corporation (LQDA) Run Higher on Rising Earnings Estimates?
Liquidia Corporation (LQDA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks·9d ago
<
1
2
...
>

Latest LQDA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.